We have shown that acute viral infections are potent stimulators of a polyclonal CD8 T cell response, eliciting cytotoxic T lymphocytes (CTL) cross-reactive with alloantigens and with other viruses in mice and stimulating a CD8 T cell-dependent autoimmune diabetes in rats. We have also found that a heterologous viral infection may prime a CTL response and provide some protective immunity to a second viral infection, and that, subsequent to the second viral infection, the memory CTL response to the first is diminished. It is my belief that, at the clonal T cell level, there may be a great deal of immunological crossreactivity between serologically distinct infectious agents, and by virtue of this crossreactivity, the host's response to infection with a given pathogen may be a reflection of its previous history of infection with a whole panoply of theoretically unrelated infectious agents; this could lead to protective """"""""natural"""""""" immunity or perhaps to more severe immunopathology. We envision an immunological network of memory cells that, by virtue of sometimes remote crossreactivities, are continually being modulated by infectious agents and other environmental antigens. We propose here to use several viruses and synthetic viral peptides to explore the specificities of virus-induced polyclonal CTL activation and to determine the significance of crossreactive CTL in """"""""natural"""""""" resistance to infection, virus-induced immunopathology, virus-induced allograft rejection, and virus-induced autoimmunity. The primary model systems will be mice infected with lymphocytic choriomeningitis (LCMV), Pichinde, vaccinia, murine cytomegalo, and some other viruses.
Specific Aim #1 will define the viral peptide and allospecificities of the CTL response to LCMV.
Specific Aim #2 analyzes CTL responses crossreactive between different viruses.
Specific Aim #3 tests several model systems for the significance of the crossreactive responses.
Specific Aim #4 examines whether some T cells are either nonspecifically stimulated during infection or else stimulated in response to induced autoantigens.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR035506-12
Application #
2633634
Study Section
Experimental Virology Study Section (EVR)
Project Start
1989-06-15
Project End
1998-12-31
Budget Start
1998-01-01
Budget End
1998-12-31
Support Year
12
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Pathology
Type
Schools of Medicine
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Waggoner, Stephen N; Cornberg, Markus; Selin, Liisa K et al. (2012) Natural killer cells act as rheostats modulating antiviral T cells. Nature 481:394-8
Selin, Liisa K; Wlodarczyk, Myriam F; Kraft, Anke R et al. (2011) Heterologous immunity: immunopathology, autoimmunity and protection during viral infections. Autoimmunity 44:328-47
Waggoner, Stephen N; Taniguchi, Ruth T; Mathew, Porunelloor A et al. (2010) Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis. J Clin Invest 120:1925-38
Kang, Yoon-Joong; Wang, Xiaosong; Lin, Sue-Jane et al. (2010) An active CD8alpha/pMHCI interaction is required for CD8 single positive thymocyte differentiation. Eur J Immunol 40:836-48
Welsh, Raymond M; Che, Jenny W; Brehm, Michael A et al. (2010) Heterologous immunity between viruses. Immunol Rev 235:244-66
Brehm, M A; Daniels, K A; Priyadharshini, B et al. (2010) Allografts stimulate cross-reactive virus-specific memory CD8 T cells with private specificity. Am J Transplant 10:1738-48
Nie, Siwei; Lin, Sue-Jane; Kim, Sung-kwon et al. (2010) Pathological features of heterologous immunity are regulated by the private specificities of the immune repertoire. Am J Pathol 176:2107-12
Cornberg, Markus; Clute, Shalyn C; Watkin, Levi B et al. (2010) CD8 T cell cross-reactivity networks mediate heterologous immunity in human EBV and murine vaccinia virus infections. J Immunol 184:2825-38
Mangada, Julie; Pearson, Todd; Brehm, Michael A et al. (2009) Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice. Diabetes 58:165-73
Seedhom, Mina O; Jellison, Evan R; Daniels, Keith A et al. (2009) High frequencies of virus-specific CD8+ T-cell precursors. J Virol 83:12907-16

Showing the most recent 10 out of 88 publications